FDA expands approval of Jardiance for patients with heart failure
Feb 28, 2022
Jardiance received approval to reduce the risk for cardiovascular death and hospitalization for patients with heart failure.
Skyrizi approved for psoriatic arthritis
Jan 26, 2022
The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
FDA approves Rinvoq for treatment of atopic Dermatitis
Jan 19, 2022
Serious side effects of Rinvoq include infections such as tuberculosis, a greater risk for death in people ages 50 years and older who have at least one cardiovascular risk factor, an increased risk for...
Most COVID-19-related EUAs not supported by high-quality evidence
Dec 30, 2021
For drugs and vaccines, the emergency use authorizations were mostly supported by randomized clinical trials.
Heart surgery patients may not need opioids at home
Dec 27, 2021
Older age, longer length of hospital stay and undergoing surgery during the past three months of the study were independent predictors of discharge without an opioid prescription.
FDA approves new drug to help control severe asthma
Dec 23, 2021
Tezspire is unique in that it only targets thymic stromal lymphopoietin, the molecule involved in airway inflammation.
FDA approves drug to help immunocompromised fend off COVID-19
Dec 09, 2021
One dose of Evusheld is administered as two separate, consecutive injections and may be effective for six months.
Prior SARS-CoV-2 infection ups protection for vaccinated
Nov 15, 2021
Prior infection was linked to a lower risk for breakthrough infection among individuals vaccinated with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna).
Medicare could negotiate drug prices under Democrat proposal
Nov 03, 2021
For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare.
CDC signs off on Moderna, J&J boosters, backs mix ‘n’ match shots
Oct 22, 2021
The agency plans to release guidance early next week about who might benefit from choosing one booster over another.